Patent ID: 11926665
Assignee: TESARO, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. A method of treating a non-small cell lung cancer in a human subject, the method comprising: (i) administering, to the human subject, a flat dose of 300 mg, once every 3 weeks (Q3W), of an anti-TIM-3 antibody that comprises a heavy chain variable domain comprising SEQ ID NO: 1 and a light chain variable domain comprising SEQ ID NO:2; (ii) administering, to the human subject, a flat dose of 500 mg, Q3W, of an anti-PD-1 antibody comprising a heavy chain comprising SEQ ID NO: 13 and a light chain comprising SEQ ID NO: 14; and, (iii) administering, to the human subject, a chemotherapeutic agent wherein the human subject has the non-small cell lung cancer.